Residency · Memphis, TN
Sponsored by University of Tennessee College of Medicine
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · John Schorge
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · John Schorge
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Todd Tillmanns
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.
Cell · 2022 · 541 citations · Eric Rios-Doria
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 346 citations · John Schorge
Artificial Intelligence and Healthcare: A Journey through History, Present Innovations, and Future Possibilities.
Life (Basel, Switzerland) · 2024 · 94 citations · Kaleb Noruzi
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 127 citations · John Schorge
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 85 citations · John Schorge